TRI has already established a Diagnostic Imaging Program as the first of its Flagship Translational Programs. The Program currently has 17 projects in various stages of development. Some are well established and undertaking clinical studies, while others are in the planning phase and awaiting ethics approval. Each addresses a clinical question with a potentially marketable solution.
The reason behind establishing a Flagship Translational Program is to attract resources that will benefit the individual projects. These resources include funding, expertise, industry collaborators and technologies. TRI Caucus is currently discussing the possibility of another Flagship Translational Program on the Microbiome.
At a meeting in March 2016, Professor Josephine Forbes, Chair of the TRI Caucus, and Professor Gerald Holtmann hosted a discussion featuring presentations from TRI-based researchers and collaborators on projects that involve the Microbiome.